Cite
HARVARD Citation
Bouman-Wammes, E. et al. (n.d.). 862TiPReCab II: A phase II trial of Cabazitaxel +/- Rhenium -188-HEDP in patients with metastatic castration resistant prostate cancer who progressed on or after a docetaxel containing treatment. Annals of oncology. p. . [Online].